Skip to main content

Peer Review reports

From: A randomised, double-masked phase III/IV study of the efficacy and safety of Avastin® (Bevacizumab) intravitreal injections compared to standard therapy in subjects with choroidal neovascularisation secondary to age-related macular degeneration: clinical trial design

Original Submission
28 Jul 2008 Submitted Original manuscript
27 Aug 2008 Reviewed Reviewer Report - Prathap Tharyan
11 Sep 2008 Author responded Author comments - Praveen Patel
Resubmission - Version 2
11 Sep 2008 Submitted Manuscript version 2
25 Sep 2008 Author responded Author comments - Praveen Patel
Resubmission - Version 3
25 Sep 2008 Submitted Manuscript version 3
Publishing
14 Oct 2008 Editorially accepted
14 Oct 2008 Article published 10.1186/1745-6215-9-56

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215